AJP - Regu Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 273: R1855-R1860, 1997;
0363-6119/97 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benloucif, S.
Right arrow Articles by Dubocovich, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benloucif, S.
Right arrow Articles by Dubocovich, M. L.

AJP - Regulatory, Integrative and Comparative Physiology, Vol 273, Issue 6 1855-R1860, Copyright © 1997 by American Physiological Society

ARTICLES

Responsiveness to melatonin and its receptor expression in the aging circadian clock of mice

S. Benloucif, M. I. Masana and M. L. Dubocovich
Department of Molecular Pharmacology and Biological Chemistry, Northwestern University Medical School, Chicago, Illinois 60611, USA.

This study determined the effect of age on the efficacy of melatonin treatment to phase shift circadian activity rhythms and on melatonin receptor expression in the suprachiasmatic nucleus (SCN) and paraventricular nucleus of the thalamus (PVNT) of C3H/HeN mice. The circadian rhythm of 2-[125I]iodomelatonin binding, assessed at three times of the day [circadian times (CT) 2, 10, and 18], showed a modest age-related decrease in the SCN but not the PVNT of old C3H/HeN mice (24 mo). There was a tendency for age to reduce Mel1a melatonin receptor mRNA expression in the suprachiasmatic nucleus during the day, but not during the night. The magnitude of phase shifts of circadian activity rhythms (advances or delays) induced by administration of melatonin at CT 10 or CT 2 was identical in young and old C3H/HeN mice. Together, these results suggest that the decrease in melatonin receptor expression in the SCN had little effect on melatonin-induced phase shifts of circadian activity rhythms. We conclude that the responsiveness of the circadian timing system to melatonin administration does not decrease with age.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
O. Van Reeth, L. Weibel, E. Olivares, S. Maccari, E. Mocaer, and F. W. Turek
Melatonin or a melatonin agonist corrects age-related changes in circadian response to environmental stimulus
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2001; 280(5): R1582 - R1591.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
X.-M. Li, X.-H. Liu, E. Filipski, G. Metzger, P. Delagrange, J.-P. Jeanniot, and F. Levi
Relationship of atypical melatonin rhythm with two circadian clock outputs in B6D2F1 mice
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2000; 278(4): R924 - R930.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
M. L. Dubocovich, K. Yun, W. M. Al-ghoul, S. Benloucif, and M. I. Masana
Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms
FASEB J, September 1, 1998; 12(12): 1211 - 1220.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online